Timolol cream for nail problems from lung cancer drugs
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests if a timolol cream can help treat painful or infected nails (paronychia) caused by certain lung cancer medications. If you have non-small cell lung cancer and nail problems from your treatment, this study may offer relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced non-small cell lung cancer.
- You take or have taken one of these lung cancer drugs: gefitinib, erlotinib, afatinib, osimertinib, amivantamab, dacomitinib, mobocertinib, crizotinib, ceritinib, alectinib, brigatinib, or lorlatinib.
- You have paronychia (pain, redness, swelling, or infection around your fingernails or toenails) caused by your lung cancer treatment.
- You are not pregnant or breastfeeding, and are willing to use the study cream.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a topical cream (HT-001) to treat skin rashes caused by EGFR inhibitors. It aims to see whether the cream is safe and can reduce rash symptoms and discomfort.
This trial tests if a topical beta-blocker (timolol) can speed up healing of skin wounds left open after surgery. It may help reduce pain and improve healing for people who choose not to have reconstructive surgery.
This trial tests whether a gel called timolol helps scalp wounds heal better and look nicer after Mohs surgery. It may reduce scarring and improve healing.
This study tests whether applying timolol (a beta-blocker eye drop) to a wound after Mohs surgery can help it heal faster. If you are having Mohs surgery for skin cancer and have a wound between half an inch and 4 inches, you may be able to join.
This trial tests if timolol eye drops, applied to the skin, can reduce red marks left by acne. It may be an option for people with acne-related redness who haven't responded to other treatments.
This trial tests whether adding the anti-inflammatory drug diclofenac can help people with advanced non-small cell lung cancer whose tumors are growing while on a single immunotherapy drug. You must have been on immunotherapy for at least 12 weeks and have a growing tumor, but your doctor does not plan to change your treatment right away.
Hear when a new Paronychia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.